Compounds > homocysteine

homocysteine and Ischemic Attack, Transient

homocysteine has been researched along with Ischemic Attack, Transient in 34 studies

Research

Studies (34)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (26.47)18.2507
2000's13 (38.24)29.6817
2010's10 (29.41)24.3611
2020's2 (5.88)2.80

Authors

AuthorsStudies
Chen, Z; Li, Y; Ma, L; Ma, Y; Meng, X1
Li, H; Li, J; Lin, J; Liu, L; Wang, A; Wang, Y; Zhao, X; Zuo, Z1
Kan, P; Wang, J; Xiang, L; Xu, N; Yang, P; Yao, X; Zhu, Y1
Gaigalaite, V; Gribauskas, P; Kalibatene, D; Ojeraitene, V; Ptasekas, J; Sabaliauskiene, Z1
Almeida, OP; Chen, C; Eikelboom, JW; Ford, AH; Gommans, J; Hankey, GJ; Lees, KR; Navarro, JC; Ranawaka, UK; Ricci, S; Schmidt, R; Uddin, W; van Bockxmeer, FM; Xavier, D; Yi, Q1
Bronić, A; Coen Herak, D; Leniček Krleža, J; Mejaški-Bošnjak, V; Zadro, R; Ðuranović, V1
Cutler, J; Rahman, Y; Sobczyńska-Malefora, A1
Basir, A; Bougteba, A; Kissani, N1
Bastounis, E; Giaginis, K; Katsargyris, A; Klonaris, C; Theocharis, SE; Tsiodras, S1
Liebeskind, DS; Ovbiagele, B; Pineda, S; Saver, JL1
Bastounis, E; Giannopoulos, A; Katsargyris, A; Klonaris, C; Theocharis, S; Tsiodras, S1
Au, R; Beiser, AS; Debette, S; DeCarli, C; Himali, JJ; Kase, CS; Kelly-Hayes, M; Meigs, JB; Pikula, A; Selhub, J; Seshadri, S; Toffler, GH; Vasan, RS; Wang, TJ; Wolf, PA1
Campolo, J; Cozzi, L; De Maria, R; Marocchi, A; Parodi, O; Parolini, M; Patrosso, MC; Penco, S1
Boysen, G; Brander, T; Christensen, H; Gideon, R; Truelsen, T1
Barron, M; Furie, KL; Kelly, PJ; Kistler, JP; Lee, H; Mandell, R; Shih, VE1
Doney, AS; MacWalter, RS; Ray, S1
Baker, R; Dusitanond, P; Eikelboom, JW; Gilmore, G; Hankey, GJ; Jamrozik, K; Klijn, CJ; Langton, P; Loh, K; Thom, J; van Bockxmeer, FM; Yi, Q1
Fields, MC; Levine, SR1
Chan, JB; Chen, CP; Eikelboom, JW; Hankey, GJ; Ho, GY; Tan, SL; Wong, CR1
Beck, J; Hinderliter, A; Offenbacher, S; Ohman, EM; Oppenheimer, SM; Sen, PK; Sen, S; Simmons, J1
Blom, HJ; Boers, GH; Franken, DG; Novakova, IR; Verrips, A; Vreugdenhil, A1
Cerbone, AM; Coppola, A; D'Angelo, A; Di Minno, G; Madonna, P; Orefice, G; Soriente, L1
Aull, S; Korninger, L; Lalouschek, W; Mannhalter, C; Pabinger-Fasching, I; Schmid, RW; Schnider, P; Zeiler, K1
Crisby, M; Eggertsen, G; Hagenfeldt, L; Hillert, J; Huang, WX; Kostulas, K; Kostulas, V; Lannfelt, L1
Aull, S; Deecke, L; Lalouschek, W; Mannhalter, C; Pabinger-Fasching, I; Schnider, P; Serles, W; Zeiler, K1
Aull, S; Deecke, L; Lalouschek, W; Lang, T; Mannhalter, C; Schnider, P; Serles, W; Zeiler, K1
Gress, DR; Singh, V1
Alvarez Sabín, J; Codina, A; Malinow, R; Montaner, J; Turón, J1
Kirkham, F; Krywawych, S; Liesner, R; Prengler, M; Sturt, N; Surtees, R1
Cohen, B; Lima, J; Oppenheimer, SM; Sen, S1
Dambinova, SA; Khounteev, GA; Skoromets, AA1
Green, R; Jagust, WJ; Miller, JW; Mungas, DM; Reed, BR1
Beamer, N; Coull, BM; de Garmo, P; Malinow, MR; Nordt, F; Sexton, G1

Reviews

3 review(s) available for homocysteine and Ischemic Attack, Transient

ArticleYear
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.
    Stroke, 2013, Volume: 44, Issue:8

    Topics: Aged; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Male; Middle Aged; Placebos; Recurrence; Stroke; Treatment Outcome; Vitamin B 12; Vitamin B Complex

2013
Stroke prevention.
    Physical medicine and rehabilitation clinics of North America, 1999, Volume: 10, Issue:4

    Topics: Cardiovascular Diseases; Fibrinolytic Agents; Homocysteine; Humans; Hypercholesterolemia; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Risk Factors; Stroke

1999
The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2002, Volume: 13, Issue:2

    Topics: Biomarkers; Brain; Disease Progression; Double-Blind Method; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamins

2002

Trials

7 trial(s) available for homocysteine and Ischemic Attack, Transient

ArticleYear
Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.
    Arteriosclerosis, thrombosis, and vascular biology, 2020, Volume: 40, Issue:3

    Topics: Aged; Aspirin; Biomarkers; China; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Risk Assessment; Risk Factors; Sex Factors; Stroke; Time Factors; Treatment Outcome

2020
Effect of B vitamins and lowering homocysteine on cognitive impairment in patients with previous stroke or transient ischemic attack: a prespecified secondary analysis of a randomized, placebo-controlled trial and meta-analysis.
    Stroke, 2013, Volume: 44, Issue:8

    Topics: Aged; Cognition Disorders; Double-Blind Method; Female; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Male; Middle Aged; Placebos; Recurrence; Stroke; Treatment Outcome; Vitamin B 12; Vitamin B Complex

2013
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy o
    Stroke, 2005, Volume: 36, Issue:1

    Topics: Biomarkers; Blood Coagulation; Cardiovascular Diseases; Endothelium, Vascular; Folic Acid; Homocysteine; Humans; Inflammation; Ischemic Attack, Transient; Pyridoxine; Risk Factors; Stroke; Vitamin B 12; Vitamin B Complex

2005
Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
    Stroke, 2006, Volume: 37, Issue:2

    Topics: Aged; Coronary Artery Disease; Dietary Supplements; Female; Folic Acid; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Dehydrogenase (NAD+); Middle Aged; Models, Statistical; Placebos; Polymorphism, Genetic; Regression Analysis; Risk Factors; Singapore; Stroke; Vitamin B 12; Vitamin B 6; Vitamins

2006
677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke.
    Journal of the neurological sciences, 1998, Mar-05, Volume: 155, Issue:2

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adult; Aged; Aged, 80 and over; Analysis of Variance; Cerebrovascular Disorders; Female; Folic Acid; Homocysteine; Humans; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases; Risk Factors; Vitamin B 12

1998
The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke.
    Cerebrovascular diseases (Basel, Switzerland), 2002, Volume: 13, Issue:2

    Topics: Biomarkers; Brain; Disease Progression; Double-Blind Method; Follow-Up Studies; Homocysteine; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Risk Factors; Stroke; Time Factors; Treatment Outcome; Vitamins

2002
Risk factors for progression of aortic atheroma in stroke and transient ischemic attack patients.
    Stroke, 2002, Volume: 33, Issue:4

    Topics: Anticoagulants; Aortic Diseases; Arteriosclerosis; Demography; Disease Progression; Echocardiography, Transesophageal; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypolipidemic Agents; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Remission, Spontaneous; Risk Factors; Stroke; Treatment Outcome

2002

Other Studies

26 other study(ies) available for homocysteine and Ischemic Attack, Transient

ArticleYear
Clinical Study of Clopidogrel Combined with Huoxue Tongluo Prescription in Improving Transient Ischemic Attack and the Effect on MMP-9, Hcy, and CRP.
    Journal of healthcare engineering, 2022, Volume: 2022

    Topics: C-Reactive Protein; Clopidogrel; Drugs, Chinese Herbal; Homocysteine; Humans; Ischemic Attack, Transient; Matrix Metalloproteinase 9; Prescriptions

2022
Astragaloside IV reversed the autophagy and oxidative stress induced by the intestinal microbiota of AIS in mice.
    Journal of microbiology (Seoul, Korea), 2018, Volume: 56, Issue:11

    Topics: Animals; Antioxidants; Autophagy; Autophagy-Related Protein 12; Bacteria; Beclin-1; Brain; Disease Models, Animal; Fatty Acids; Feces; Gastrointestinal Microbiome; Genetic Vectors; Glutathione; Homocysteine; Ischemic Attack, Transient; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; NADPH Oxidase 2; NADPH Oxidase 4; Oxidative Stress; Reactive Oxygen Species; Saponins; Stroke; Superoxide Dismutase; Triterpenes

2018
[Homocysteine levels and platelet aggregation in patients with cerebral circulatory disorders].
    Terapevticheskii arkhiv, 2013, Volume: 85, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Brain Ischemia; Cerebrovascular Circulation; Collagen; Female; Homocysteine; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation; Severity of Illness Index; Stroke

2013
Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack.
    Croatian medical journal, 2013, Volume: 54, Issue:4

    Topics: Adolescent; Antithrombin III; Blood Coagulation Disorders; Child; Cholesterol; Croatia; Female; Homocysteine; Humans; Ischemic Attack, Transient; Lupus Coagulation Inhibitor; Male; Protein C; Protein S; Risk Factors; Stroke

2013
Elevated homocysteine with pseudo-homozygosity for MTHFR677T as predisposing factors for transient ischemic attacks: a case report.
    Metabolic brain disease, 2016, Volume: 31, Issue:5

    Topics: Biomarkers; Homocysteine; Homozygote; Humans; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Reductase (NADPH2); Young Adult

2016
[Recurrent ischemic stroke revealing Biermer's disease].
    Revue neurologique, 2009, Volume: 165, Issue:12

    Topics: Anemia, Pernicious; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Recurrence; Vitamin B 12

2009
Enhanced TLR4 endothelial cell immunohistochemical expression in symptomatic carotid atherosclerotic plaques.
    Expert opinion on therapeutic targets, 2010, Volume: 14, Issue:1

    Topics: Aged; Amaurosis Fugax; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Atherosclerosis; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Endarterectomy, Carotid; Endothelial Cells; Female; Graft Occlusion, Vascular; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Ischemic Attack, Transient; Male; Stroke; Thrombosis; Toll-Like Receptor 4

2010
Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack.
    Archives of neurology, 2010, Volume: 67, Issue:1

    Topics: Atrial Fibrillation; Biomarkers; Brain; Cerebral Arteries; Cerebral Hemorrhage; Cross-Sectional Studies; Diffusion Magnetic Resonance Imaging; Female; Homocysteine; Humans; Ischemic Attack, Transient; Male; Middle Aged; Proteinuria; Risk Factors; Sex Distribution; Stroke

2010
Statin treatment is associated with reduced toll-like receptor 4 immunohistochemical expression on carotid atherosclerotic plaques: a novel effect of statins.
    Vascular, 2011, Volume: 19, Issue:6

    Topics: Aged; C-Reactive Protein; Carotid Arteries; Carotid Stenosis; Endarterectomy; Female; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Ischemic Attack, Transient; Male; Risk Factors; Stroke; Toll-Like Receptor 4

2011
Multiple biomarkers and risk of clinical and subclinical vascular brain injury: the Framingham Offspring Study.
    Circulation, 2012, May-01, Volume: 125, Issue:17

    Topics: Aged; Albuminuria; Biomarkers; Blood Proteins; Brain; Brain Injuries; Cohort Studies; Creatinine; Endothelium, Vascular; Female; Hemostasis; Homocysteine; Hormones; Humans; Incidence; Inflammation; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Prospective Studies; Risk; Stroke; United States

2012
Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis.
    Molecular and cellular biochemistry, 2013, Volume: 374, Issue:1-2

    Topics: Alleles; Aryldialkylphosphatase; Cysteine; Female; Genetic Predisposition to Disease; Genotype; Glutathione; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Middle Aged; Myocardial Infarction; Oxidative Stress; Polymorphism, Single Nucleotide; Risk Factors; Stroke; Thrombosis

2013
Homocysteine and risk of recurrent stroke.
    Stroke, 2003, Volume: 34, Issue:5

    Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Denmark; Diabetes Mellitus; Female; Follow-Up Studies; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Odds Ratio; Prospective Studies; Recurrence; Risk; Risk Factors; Smoking; Stroke

2003
Low vitamin B6 but not homocyst(e)ine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification.
    Stroke, 2003, Volume: 34, Issue:6

    Topics: Case-Control Studies; Comorbidity; Edible Grain; Female; Folic Acid; Food, Fortified; Homocysteine; Homocystine; Humans; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Odds Ratio; Oxidoreductases Acting on CH-NH Group Donors; Pyridoxal Phosphate; Risk Assessment; Risk Factors; Serum Albumin; Stroke; United States; Vitamin B 12; Vitamin B 6

2003
Secondary prevention for stroke and transient ischaemic attacks: Horizons needs expanding.
    BMJ (Clinical research ed.), 2004, Apr-10, Volume: 328, Issue:7444

    Topics: Blood Glucose; Homocysteine; Humans; Ischemic Attack, Transient; Risk Factors; Stroke

2004
Thrombophilias and stroke: diagnosis, treatment, and prognosis.
    Journal of thrombosis and thrombolysis, 2005, Volume: 20, Issue:2

    Topics: Anticoagulants; Cystathionine beta-Synthase; Factor V; Genetic Predisposition to Disease; Genetic Testing; Homocysteine; Humans; Hyperhomocysteinemia; Ischemic Attack, Transient; Methylenetetrahydrofolate Reductase (NADPH2); Platelet Activation; Platelet Aggregation; Polymorphism, Genetic; Prognosis; Protein S Deficiency; Prothrombin; Secondary Prevention; Stroke; Thrombophilia; Warfarin

2005
Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack.
    Circulation, 2007, Aug-21, Volume: 116, Issue:8

    Topics: Aged; Aorta, Thoracic; Atherosclerosis; Disease Progression; Disease-Free Survival; Echocardiography, Transesophageal; Female; Follow-Up Studies; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Kaplan-Meier Estimate; Male; Middle Aged; Prevalence; Recurrence; Risk Factors; Stroke

2007
Familial cerebrovascular accidents due to concomitant hyperhomocysteinemia and protein C deficiency type 1.
    Stroke, 1993, Volume: 24, Issue:10

    Topics: Adolescent; Adult; Amino Acid Metabolism, Inborn Errors; Cerebrovascular Disorders; Female; Homocysteine; Humans; Ischemic Attack, Transient; Male; Protein C Deficiency; Risk Factors

1993
Homozygous C677T mutation of the 5,10 methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in Italian patients with a history of early-onset ischemic stroke.
    Stroke, 1998, Volume: 29, Issue:4

    Topics: 5,10-Methylenetetrahydrofolate Reductase (FADH2); Adolescent; Adult; Age of Onset; Case-Control Studies; Child; Child, Preschool; Female; Homocysteine; Homozygote; Humans; Ischemic Attack, Transient; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases

1998
A methylenetetrahydrofolate reductase gene polymorphism in ischaemic stroke and in carotid artery stenosis.
    European journal of clinical investigation, 1998, Volume: 28, Issue:4

    Topics: Age Factors; Age of Onset; Aged; Carotid Artery, Internal; Carotid Stenosis; DNA; Female; Gene Frequency; Genotype; Homocysteine; Humans; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Polymorphism, Genetic; Reference Values

1998
C677T MTHFR mutation and factor V Leiden mutation in patients with TIA/minor stroke: a case-control study.
    Thrombosis research, 1999, Jan-15, Volume: 93, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Cerebrovascular Disorders; Factor V; Female; Homocysteine; Humans; Ischemic Attack, Transient; Male; Middle Aged; Point Mutation; Risk Factors; Tetrahydrofolates

1999
Genetic and nongenetic factors influencing plasma homocysteine levels in patients with ischemic cerebrovascular disease and in healthy control subjects.
    The Journal of laboratory and clinical medicine, 1999, Volume: 133, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Female; Folic Acid; Genotype; Homocysteine; Humans; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Oxidoreductases Acting on CH-NH Group Donors; Vitamin B 12

1999
[Plasma homocysteine levels in patients with transient ischemic attacks].
    Medicina clinica, 1999, Oct-30, Volume: 113, Issue:14

    Topics: Adult; Aged; Carotid Stenosis; Female; Folic Acid; Homocysteine; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Risk Factors; Severity of Illness Index; Tomography, X-Ray Computed

1999
Homozygous thermolabile variant of the methylenetetrahydrofolate reductase gene: a potential risk factor for hyperhomocysteinaemia, CVD, and stroke in childhood.
    Developmental medicine and child neurology, 2001, Volume: 43, Issue:4

    Topics: Adolescent; Alleles; Cerebrovascular Disorders; Child; Child, Preschool; Female; Genetic Predisposition to Disease; Homocysteine; Homozygote; Humans; Infant; Ischemic Attack, Transient; Male; Methylenetetrahydrofolate Reductase (NADPH2); Oxidoreductases Acting on CH-NH Group Donors; Recurrence; Risk Factors; Stroke; Temperature

2001
Multiple panel of biomarkers for TIA/stroke evaluation.
    Stroke, 2002, Volume: 33, Issue:5

    Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Autoantibodies; Biomarkers; Diagnosis, Differential; Disease Progression; Female; Glutamic Acid; Glycine; Homocysteine; Humans; Hypertension; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Neuroprotective Agents; Predictive Value of Tests; Receptors, N-Methyl-D-Aspartate; Stroke; Tomography, X-Ray Computed

2002
Homocysteine, vitamin B6, and vascular disease in AD patients.
    Neurology, 2002, May-28, Volume: 58, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Angina Pectoris; Brain Infarction; Coronary Disease; Female; Heart Failure; Homocysteine; Humans; Ischemic Attack, Transient; Male; Myocardial Infarction; Odds Ratio; Pyridoxal Phosphate; Stroke; Vascular Diseases; Vitamin B 6

2002
Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
    Stroke, 1990, Volume: 21, Issue:4

    Topics: Cerebrovascular Disorders; Homocysteine; Humans; Ischemic Attack, Transient; Osmolar Concentration; Risk Factors; Sex Factors

1990